gptkbp:instanceOf
|
Hallucinogen
ergoline derivative
|
gptkbp:abbreviation
|
gptkb:Lysergsäurediethylamid
|
gptkbp:abusePotential
|
low
|
gptkbp:allows
|
rapidly develops
rapidly diminishes after cessation
|
gptkbp:aroma
|
odorless
|
gptkbp:CASNumber
|
50-37-3
|
gptkbp:category
|
Hallucinogen
recreational drug
serotonergic psychedelic
tryptamine
psychedelic phenethylamine
|
gptkbp:chemicalClass
|
gptkb:lysergic_acid_diethylamide
|
gptkbp:chemicalFormula
|
C20H25N3O
|
gptkbp:color
|
colorless
|
gptkbp:contraindication
|
schizophrenia
pregnancy
psychosis
|
gptkbp:discoveredBy
|
gptkb:Albert_Hofmann
|
gptkbp:discoveredIn
|
1938
|
gptkbp:duration
|
8–12 hours
|
gptkbp:effect
|
euphoria
hallucinations
synesthesia
altered perception
spiritual experiences
|
gptkbp:eliminationHalfLife
|
3–5 hours
|
gptkbp:excretion
|
renal
|
gptkbp:firstSynthesizedAt
|
gptkb:Sandoz_Laboratories
|
https://www.w3.org/2000/01/rdf-schema#label
|
LSD-25
|
gptkbp:legalStatus
|
gptkb:Schedule_I_(US)
gptkb:Class_A_(UK)
illegal in most countries
|
gptkbp:mainStreet
|
gptkb:carboxylic_acid
gptkb:Lucy
gptkb:window_pane
blotter
dots
tabs
cid
microdot
|
gptkbp:mechanismOfAction
|
serotonin receptor agonist
|
gptkbp:meltingPoint
|
80–85 °C
|
gptkbp:metabolism
|
hepatic
|
gptkbp:molecularWeight
|
323.43 g/mol
|
gptkbp:notableEvent
|
gptkb:Bicycle_Day
first intentional ingestion by Albert Hofmann in 1943
|
gptkbp:onset
|
30–60 minutes
|
gptkbp:overdoseSymptoms
|
extremely low
|
gptkbp:PubChem_CID
|
5761
CHEMBL27
|
gptkbp:relatedTo
|
gptkb:ergot_alkaloids
gptkb:DMT
psilocybin
mescaline
|
gptkbp:routeOfAdministration
|
oral
intramuscular
transdermal
intravenous
sublingual
|
gptkbp:sideEffect
|
gptkb:hallucinogen_persisting_perception_disorder
nausea
anxiety
loss of appetite
paranoia
increased heart rate
sweating
insomnia
flashbacks
dry mouth
tremors
visual disturbances
delusions
increased blood pressure
dilated pupils
|
gptkbp:solubility
|
water-soluble
chloroform-soluble
ethanol-soluble
|
gptkbp:toxicity
|
very low
|
gptkbp:UNII
|
9D2B72Q28F
|
gptkbp:usedIn
|
gptkb:MKUltra_experiments
psychedelic therapy
recreational drug
|
gptkbp:bfsParent
|
gptkb:lysergic_acid_diethylamide
|
gptkbp:bfsLayer
|
6
|